Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary centre among diabetic patients exposed to gliptins between the years 2008-2021. Data including demographics, comorbidities, medications, and laboratory results were collected using the MDClone platform. Seventy-six patients with type 2 diabetes treated with dipeptidyl-peptidase 4 inhibitors who subsequently developed bullous pemphigoid were compared with a cohort of 8,060 diabetic patients exposed to dipeptidyl-peptidase 4 inhibitors who did not develo...
Source: Acta Derm Venereol A... - April 5, 2024 Category: Dermatology Authors: Dana Shalmon Efrat Bar-Ilan Alon Peled Shamir Geller Jonathan Bar Naama Schwartz Eli Sprecher Mor Pavlovsky Source Type: research
Prolonged suppressive antibiotic therapy for inferior vena cava filter infection following emphysematous pyelonephritis and cystitis: a case report
CONCLUSION: Infections of implanted devices, such as IVC filters, secondary to severe infections can cause persistent bacteremia. PSAT may be an alternative option to treat IVC filter infection, when the IVC filter is considered difficult to remove.PMID:38576969 | PMC:PMC10990323 | DOI:10.1097/MS9.0000000000001886 (Source: Annals of Medicine)
Source: Annals of Medicine - April 5, 2024 Category: Internal Medicine Authors: Yasuhiro Suzuki Akira Kuriyama Source Type: research
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary centre among diabetic patients exposed to gliptins between the years 2008-2021. Data including demographics, comorbidities, medications, and laboratory results were collected using the MDClone platform. Seventy-six patients with type 2 diabetes treated with dipeptidyl-peptidase 4 inhibitors who subsequently developed bullous pemphigoid were compared with a cohort of 8,060 diabetic patients exposed to dipeptidyl-peptidase 4 inhibitors who did not develo...
Source: Acta Dermato-Venereologica - April 5, 2024 Category: Dermatology Authors: Dana Shalmon Efrat Bar-Ilan Alon Peled Shamir Geller Jonathan Bar Naama Schwartz Eli Sprecher Mor Pavlovsky Source Type: research
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary centre among diabetic patients exposed to gliptins between the years 2008-2021. Data including demographics, comorbidities, medications, and laboratory results were collected using the MDClone platform. Seventy-six patients with type 2 diabetes treated with dipeptidyl-peptidase 4 inhibitors who subsequently developed bullous pemphigoid were compared with a cohort of 8,060 diabetic patients exposed to dipeptidyl-peptidase 4 inhibitors who did not develo...
Source: Acta Derm Venereol A... - April 5, 2024 Category: Dermatology Authors: Dana Shalmon Efrat Bar-Ilan Alon Peled Shamir Geller Jonathan Bar Naama Schwartz Eli Sprecher Mor Pavlovsky Source Type: research
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary centre among diabetic patients exposed to gliptins between the years 2008-2021. Data including demographics, comorbidities, medications, and laboratory results were collected using the MDClone platform. Seventy-six patients with type 2 diabetes treated with dipeptidyl-peptidase 4 inhibitors who subsequently developed bullous pemphigoid were compared with a cohort of 8,060 diabetic patients exposed to dipeptidyl-peptidase 4 inhibitors who did not develo...
Source: Acta Dermato-Venereologica - April 5, 2024 Category: Dermatology Authors: Dana Shalmon Efrat Bar-Ilan Alon Peled Shamir Geller Jonathan Bar Naama Schwartz Eli Sprecher Mor Pavlovsky Source Type: research
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary centre among diabetic patients exposed to gliptins between the years 2008-2021. Data including demographics, comorbidities, medications, and laboratory results were collected using the MDClone platform. Seventy-six patients with type 2 diabetes treated with dipeptidyl-peptidase 4 inhibitors who subsequently developed bullous pemphigoid were compared with a cohort of 8,060 diabetic patients exposed to dipeptidyl-peptidase 4 inhibitors who did not develo...
Source: Acta Derm Venereol A... - April 5, 2024 Category: Dermatology Authors: Dana Shalmon Efrat Bar-Ilan Alon Peled Shamir Geller Jonathan Bar Naama Schwartz Eli Sprecher Mor Pavlovsky Source Type: research
The Koebner Phenomenon in Bullous Pemphigoid
J Drugs Dermatol. 2024 Apr 1;23(4):e100-e101. doi: 10.36849/JDD.7796.NO ABSTRACTPMID:38564388 | DOI:10.36849/JDD.7796 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - April 2, 2024 Category: Dermatology Authors: Payal Shah Akonam Olivia Anakwe Jenne Ingrassia Eamonn Maher Avrom Caplan Prince Adotama Source Type: research
